Home

Szivárvány kiáll Gondos olvasás ci adv 2 e1501244 2016 Dekoráció Írjon egy jelentést Webhely vonal

Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and  Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience
Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience

Rational design of a conformation-specific antibody for the quantification  of Aβ oligomers. - Abstract - Europe PMC
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers. - Abstract - Europe PMC

An anticancer drug suppresses the primary nucleation reaction that  initiates the production of the toxic Aβ42 aggregates linked with  Alzheimer's disease | Science Advances
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances

PDF) Small molecule-mediated co-assembly of amyloid-β oligomers reduces  neurotoxicity through promoting non-fibrillar aggregation
PDF) Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation

Two decades of new drug discovery and development for Alzheimer's disease
Two decades of new drug discovery and development for Alzheimer's disease

Small-molecule sequestration of amyloid-β as a drug discovery strategy for  Alzheimer's disease | Science Advances
Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease | Science Advances

Small molecule-mediated co-assembly of amyloid-β oligomers reduces  neurotoxicity through promoting non-fibrillar aggregation - Chemical  Science (RSC Publishing) DOI:10.1039/D0SC00392A
Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation - Chemical Science (RSC Publishing) DOI:10.1039/D0SC00392A

Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation:  Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer's  Disease | ACS Chemical Neuroscience
Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer's Disease | ACS Chemical Neuroscience

An anticancer drug suppresses the primary nucleation reaction that  initiates the production of the toxic Aβ42 aggregates linked with  Alzheimer's disease | Science Advances
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances

A spiral microfluidic device for rapid sorting, trapping, and long-term  live imaging of Caenorhabditis elegans embryos | Microsystems &  Nanoengineering
A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering

Small-molecule sequestration of amyloid-β as a drug discovery strategy for  Alzheimer's disease | Science Advances
Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease | Science Advances

Two decades of new drug discovery and development for Alzheimer's disease -  RSC Advances (RSC Publishing) DOI:10.1039/C6RA26737H
Two decades of new drug discovery and development for Alzheimer's disease - RSC Advances (RSC Publishing) DOI:10.1039/C6RA26737H

PDF) A rationally designed bicyclic peptide remodels Aβ42 aggregation in  vitro and reduces its toxicity in a worm model of Alzheimer's disease
PDF) A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease

A spiral microfluidic device for rapid sorting, trapping, and long-term  live imaging of Caenorhabditis elegans embryos | Microsystems &  Nanoengineering
A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering

PDF) Exogenous misfolded protein oligomers can cross the intestinal barrier  and cause a disease phenotype in C. elegans
PDF) Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans

Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and  Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience
Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience

An anticancer drug suppresses the primary nucleation reaction that  initiates the production of the toxic Aβ42 aggregates linked with  Alzheimer's disease | Science Advances
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances

Selective targeting of primary and secondary nucleation pathways in Aβ42  aggregation using a rational antibody scanning method | Science Advances
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method | Science Advances

IJMS | Free Full-Text | Rationally Designed Antibodies as Research Tools to  Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
IJMS | Free Full-Text | Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers

Drug discovery: Insights from the invertebrate Caenorhabditis elegans -  Giunti - 2021 - Pharmacology Research & Perspectives - Wiley Online Library
Drug discovery: Insights from the invertebrate Caenorhabditis elegans - Giunti - 2021 - Pharmacology Research & Perspectives - Wiley Online Library

PDF) Delivery of Native Proteins into C. Elegans Using a Transduction  Protocol Based on Lipid Vesicles
PDF) Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles

Genetic and Pharmacological Discovery for Alzheimer's Disease Using  Caenorhabditis elegans | ACS Chemical Neuroscience
Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans | ACS Chemical Neuroscience

PDF) Systematic development of small molecules to inhibit specific  microscopic steps of Aβ42 aggregation in Alzheimer's disease
PDF) Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease

Rational design of a conformation-specific antibody for the quantification  of Aβ oligomers | PNAS
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers | PNAS

Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for  Alzheimer's Disease | ACS Chemical Neuroscience
Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer's Disease | ACS Chemical Neuroscience

Glycation affects fibril formation of Aβ peptides - ScienceDirect
Glycation affects fibril formation of Aβ peptides - ScienceDirect